YOU MAY BE QUALIFIED IF YOU:
Are 13 - 19 years old
Are experiencing symptoms of Attention Deficit Hyperactivity Disorder (ADHD), for example: trouble paying attention, easily distracted, feeling restless
Smoke marijuana and tobacco regularly
Are willing to take medication or placebo (inactive substance/sugar pill) for ADHD
If you meet the criteria above, you may be eligible to participate in a confidential research study being conducted at the University of Colorado Denver. The purpose of this study is to find out if a medication called bupropion SR can help teenagers with ADHD and marijuana and tobacco problems.
Final eligibility will be determined during two screening visits conducted by trained professional and supervised by a psychiatrist.
If you are found eligible, you would then qualify for the 16-week study, which involves:
- being assigned at random to receive bupropion or placebo; you will be taking the medication or placebo every day for sixteen weeks
- meeting weekly with the research nurse
- participating in weekly 1-hour Cognitive-Behavioral Therapy sessions
- answering questions about your drug use and ADHD
- giving a urine sample to test for drugs of abuse
You will be compensated for your time and travel.
This study is funded by a grant from the National Institute on Drug Abuse (NIDA R01 DA022284)
Approved by COMIRB, #08-0178
The study Principal Investigator is Paula Riggs, MD, Professor of Psychiatry, UC Denver, (303) 935-5892